The Food and Drug Administration granted 21 spine-related clearances in March.
Spinal Tech
The FDA's Orthopaedic and Rehabilitation Devices Panel has voted in favor of the safety and efficacy of the Cartiva Synthetic Cartilage Implant.
Stryker has completed its acquisition of the CareFusion vertebral compression fracture portfolio of products from Becton, Dickinson and Company.
Here are 14 key notes on orthopedic and spine device companies over the past week.
Oxford Finance and Silicon Valley Bank closed a $45 million term loan to Plano, Texas-based Nuvectra, according to ABL Advisor.
Advertisement
The global bone grafts and substitutes market is expected to increase to $3.48 billion by 2023, up from $2.35 billion in 2014, according to MedGadget.
On April 22, Integra LifeSciences' shares were up 0.17 percent, according to Risers & Fallers.
Three health-focused startups are making a splash as part of Baltimore-based Johns Hopkins Social Innovations Lab, according to Technical.ly.
Stryker reported strong financial growth for the first quarter of 2016.
SI-BONE published two-year results from SIFI, a prospective multicenter clinical trial of SI joint fusion using its iFuse Implant System.